NDC 58468-0229 - Cablivi
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58468-0229
- Package NDCs from labels
- 58468-0229-1
- Manufacturer
- Genzyme Corporation | Richter Helm Biologics GmbH and Co KG (Bovenau) | Richter Helm Biologics GmbH and Co KG (Hamburg) | Patheon Italia S.p.A. | Ablynx | Enestia Belgium NV (trading as Sharp Packaging Solutions)
- Effective date
- 2026-04-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cablivi | Genzyme Corporation | Richter Helm Biologics GmbH and Co KG (Bovenau) | Richter Helm Biologics GmbH and Co KG (Hamburg) | Patheon Italia S.p.A. | Ablynx | Enestia Belgium NV (trading as Sharp Packaging Solutions) | 2026-04-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 58468-0229 | CABLIVI (CAPLACIZUMAB) KIT [GENZYME CORPORATION] | 14 | Unmatched | 20241108_2348f06e-8004-4040-832e-e9e86a39f905.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eye Wash | WATER | CVS Pharmacy | 049cee29-7ec2-4d5b-8308-f522acde43a7 | 2017-03-29 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 051f7347-5a76-4664-8fe2-e61b3dfcb0e4 | 2014-08-27 | XF417D3PSL B22547B95K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.